Identification of active compounds of traditional chinese medicine derived from maxing shigan decoction for COVID-19 treatment: a meta-analysis and in silico study-Reference-Cited by-同舟云学术

Identification of active compounds of traditional chinese medicine derived from maxing shigan decoction for COVID-19 treatment: a meta-analysis and in silico study

Published:2023-07-23 Issue:8 Volume:21 Page:871-889
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Guo Xiaodan¹,Lin Yihua²,He Fengming¹,Jin Ying³,Chen Simian¹,Li Ting¹,Wu Caisheng¹,Zhang Lin⁴,Chen Xueqin⁵

Affiliation:

1. Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Xiamen University, Xiamen, China

2. Department of Respiratory and Critical Care Medicine, School of Medicine, Xiamen University, Xiamen, China

3. Department of Cardiology, Xiamen Key Laboratory of Cardiac Electrophysiology, Xiamen Institute of Cardiovascular Diseases, School of Medicine, Xiamen University, Xiamen, China

4. School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

5. Department of Traditional Chinese Medicine, School of Medicine, Xiamen University, Xiamen, China

Funder

Fujian Province Science and Technology Project

Ministry of Science and Technology

National Natural Science Foundation of China

Xiamen Municipal Bureau of Science and Technology Planning Project

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link